Search

for
Search:

Sort by

Research

450-480 / 1000+ results

research An assessment of (1) cyproterone acetate and (2) ethinyl oestradiol and lynoestrenol (Minilyn) in the treatment of idiopathic hirsutism

8 citations , November 1978 in “British journal of dermatology/British journal of dermatology, Supplement”

Cyproterone acetate can effectively treat idiopathic hirsutism, but ethinyl oestradiol and lynoestrenol may not always reduce hair growth.

research Treatment of Vulvovaginal Erosive and Stenosing Lichen Planus by Surgical Dilatation and Methotrexate

October 2007 in “Obstetrical & Gynecological Survey”

Low-dose methotrexate, combined with surgical and local treatments, effectively treats severe vulvovaginal lichen planus.

research Synthesis and Evaluation of 2‘-Substituted 4-(4‘-Carboxy- or 4‘-carboxymethylbenzylidene)-N-acylpiperidines: Highly Potent and in Vivo Active Steroid 5α-Reductase Type 2 Inhibitors

22 citations , June 2002 in “Journal of Medicinal Chemistry”

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

research Pharmacology and Potential Use of Cyproterone Acetate

129 citations , January 1977 in “Hormone and metabolic research”

Cyproterone Acetate effectively treats androgen-related conditions and is used in prostate cancer therapy and hormone therapy for transgender women.

research [Long-term treatment of virilized women with cyproterone acetate (author's transl)].

1 citations , September 1981 in “PubMed”

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

research Low leptin level in an obese hyperandrogenic woman – potential marker for androgen-secreting tumor

4 citations , January 2007 in “Gynecological endocrinology”

Low leptin levels in obese women with high testosterone may indicate a tumor that secretes male hormones.

Probing Androgen Receptor Co-Factor Selectivity Profiles: A Chemical Tool to Determine Cross-Talk Between Androgen Receptor and Beta-Catenin In Vivo

research Probing androgen receptor co-factor selectivity profiles: a chemical tool to determine cross-talk between androgen receptor and β-catenin in vivo

1 citations , January 2013 in “MedChemComm”

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Real-Life Experience with Belimumab in Systemic Lupus Erythematosus: Control of Disease Activity and Flares in a Multicenter Cohort

research AB0442 Real-life experience with belimumab in systemic lupus erythematosus (SLE): control of disease activity and flares in a multicenter cohort

2 citations , June 2017

Belimumab effectively controls SLE disease activity and reduces steroid use.

research Inhibition of progesterone metabolism mimics the effect of progesterone withdrawal on forced swim test immobility

60 citations , June 2007 in “Pharmacology Biochemistry and Behavior”

Blocking progesterone metabolism can cause depression-like behavior in mice.

research MP89-08 POST-FINASTERIDE SYNDROME: REAL OR IMAGINED?

2 citations , March 2016 in “The Journal of Urology”

Finasteride 1mg linked to diverse symptoms; other treatments improve erectile function in rats.

research Study on inhibitory effect of Urtica laetevirens Maxim. extract on 5α-reductase

January 2014

Urtica laetevirens extract significantly reduces 5α-reductase activity.

research Finasteride blocks progesterone synthesis in MA-10 Leydig tumor cells.

6 citations , October 1993 in “Endocrinology”

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

research A(1-7) reduces pathologies associated with SLE in MRL-lpr mice

May 2018 in “The Journal of Immunology”

A(1-7) treatment reduces symptoms of lupus in mice.

research [Two drugs have a better outcome. Finasteride plus alpha blocker improves urine flow].

November 2003 in “PubMed”

research Actualités du SOPK

December 2006 in “Annales D Endocrinologie”

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.